Achilles Therapeutics
Achilles Therapeutics is a biopharmaceutical company focused on developing precision T cell therapies for the treatment of cancer. Leveraging advanced bioinformatics and genomics, Achilles Therapeutics identifies and targets clonal neoantigens unique to each patient’s tumor, aiming to deliver personalized immunotherapies with high specificity and efficacy. The company’s innovative approach is designed to harness the immune system to recognize and eliminate cancer cells while minimizing impact on healthy tissue. Achilles Therapeutics is committed to advancing clinical programs and research in oncology, with the goal of transforming the standard of care for patients with solid tumors through next-generation cell therapy solutions.
